GlassScriptPhysician profile
Scott L Beau
NPI 1861485302
$6,318.70
in general payments reported to CMS, 2019-2025
22 companies · $596 in 2025
The $596 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,183 · 2020: $299 · 2021: $315 · 2022: $419 · 2023: $439 · 2024: $1,066 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,764.73 | 2019-2025 | Aveir, Mitraclip, Quadra Assura |
| Boston Scientific Corporation | $625.50 | 2019-2025 | Cds - Mct/Cem Monitoring |
| Atricure, INC. | $553.47 | 2019-2021 | |
| Avinger INC. | $271.24 | 2022-2023 | Pantheris |
| Philips North America LLC | $192.58 | 2019 | |
| Medtronic, INC. | $187.07 | 2021-2025 | Micra |
| Abiomed | $150.52 | 2019 | |
| Penumbra, INC. | $66.36 | 2024 | Indigo System |
| Medtronic Vascular, INC. | $65.49 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.65 | 2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $58.55 | 2023-2024 | |
| Elutia, INC. | $50.50 | 2023-2024 | Ecm Patch,Pouch |
| Biotronik INC. | $48.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $41.51 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $37.12 | 2024-2025 | Eliquis, Camzyos |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $37.07 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Inari Medical, INC. | $28.19 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $19.53 | 2023 | |
| Bridgebio Pharma, INC. | $19.36 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $15.55 | 2024 | Farxiga |
| Cardiovascular Systems INC. | $13.64 | 2019 | |
| Cardiva Medical, INC. | $13.46 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Beau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.